Close Menu

NEW YORK (GenomeWeb) – Emedgene, a startup developer of automated genomic interpretation software, said today that it has raised $6 million in a Series A funding round led by Olive Tree Ventures.

The Palo Alto, California-based company with Israeli roots said that it will use the money to expand its US sales operations. CEO Einat Metzer has moved to Silicon Valley, though R&D operations remain in Tel Aviv, a company spokeswoman said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Associated Press reports that a state board in Texas has asked ANDE, a maker of rapid DNA machines, to halt its work there.

James Wyngaarden, the former director of the US National Institutes of Health, has died at 94, according to Duke University School of Medicine.

Researchers find that a 30-year-old skull comes from a narwhal-beluga hybrid, according to Science News.

In Nature this week: study of value diversity in GWAS, Epstein-Barr virus subtypes linked to nasopharyngeal carcinoma risk, and more.